VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 107 filers reported holding VAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $44,613,793 | -21.8% | 1,190,336 | 0.0% | 0.73% | -35.1% |
| Q4 2022 | $57,076,611 | -27.6% | 1,190,336 | -63.8% | 1.12% | -13.2% |
| Q3 2022 | $78,852,000 | -1.2% | 3,285,504 | -10.4% | 1.29% | +4.7% |
| Q2 2022 | $79,803,000 | -18.5% | 3,667,425 | -9.6% | 1.23% | +1.9% |
| Q1 2022 | $97,930,000 | -2.2% | 4,055,092 | -3.6% | 1.21% | +21.1% |
| Q4 2021 | $100,098,000 | – | 4,207,575 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |